Docsun Biomed Report On the New COVID 19 Variant Omicron

On November 26, 2021, the World Health Organization (WHO) classified a new variant, B.1.1.529, as a Variant of Concern and has named it Omicron. No cases of this variant have been identified in the U.S. to date. CDC is following the details of this new variant, first reported to the WHO by South Africa.

The Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) is an independent group of experts that periodically monitors and evaluates the evolution of SARS-CoV-2 and assesses if specific mutations and combinations of mutations alter the behaviour of the virus. The TAG-VE was convened on 26 November 2021 to assess the SARS-CoV-2 variant: B.1.1.529.

The B.1.1.529 variant was first reported to WHO from South Africa on 24 November 2021. The epidemiological situation in South Africa has been characterized by three distinct peaks in reported cases, the latest of which was predominantly the Delta variant. In recent weeks, infections have increased steeply, coinciding with the detection of B.1.1.529 variant. The first known confirmed B.1.1.529 infection was from a specimen collected on 9 November 2021.

This variant has a large number of mutations, some of which are concerning. Preliminary evidence suggests an increased risk of reinfection with this variant, as compared to other VOCs. The number of cases of this variant appears to be increasing in almost all provinces in South Africa. Current SARS-CoV-2 PCR diagnostics continue to detect this variant. Several labs have indicated that for one widely used PCR test, one of the three target genes is not detected (called S gene dropout or S gene target failure) and this test can therefore be used as marker for this variant, pending sequencing confirmation. Using this approach, this variant has been detected at faster rates than previous surges in infection, suggesting that this variant may have a growth advantage.

There are a number of studies underway and the TAG-VE will continue to evaluate this variant. WHO will communicate new findings with Member States and to the public as needed.

Based on the evidence presented indicative of a detrimental change in COVID-19 epidemiology, the TAG-VE has advised WHO that this variant should be designated as a VOC, and the WHO has designated B.1.1.529 as a VOC, named Omicron.

As such, countries are asked to do the following:

  • Enhance surveillance and sequencing efforts to better understand circulating SARS-CoV-2 variants.
  • Submit complete genome sequences and associated metadata to a publicly available database, such as GISAID.
  • Report initial cases/clusters associated with VOC infection to WHO through the IHR mechanism.
  • Where capacity exists and in coordination with the international community, perform field investigations and laboratory assessments to improve understanding of the potential impacts of the VOC on COVID-19 epidemiology, severity, effectiveness of public health and social measures, diagnostic methods, immune responses, antibody neutralization, or other relevant characteristics.

Individuals are reminded to take measures to reduce their risk of COVID-19, including proven public health and social measures such as wearing well-fitting masks, hand hygiene, physical distancing, improving ventilation of indoor spaces, avoiding crowded spaces, and getting vaccinated.

For reference, WHO has working definitions for SARS-CoV-2 Variant of Interest (VOI) and Variant of Concern (VOC).

A SARS-CoV-2 VOI is a SARS-CoV-2 variant:

With genetic changes that are predicted or known to affect virus characteristics such as transmissibility, disease severity, immune escape, diagnostic or therapeutic escape; AND

That has been identified as causing significant community transmission or multiple COVID-19 clusters, in multiple countries with increasing relative prevalence alongside increasing number of cases over time, or other apparent epidemiological impacts to suggest an emerging risk to global public health.

A SARS-CoV-2 VOC is a SARS-CoV-2 variant that meets the definition of a VOI (see above) and, through a comparative assessment, has been demonstrated to be associated with one or more of the following changes at a degree of global public health significance:

  • Increase in transmissibility or detrimental change in COVID-19 epidemiology; OR
  • Increase in virulence or change in clinical disease presentation; OR
  • Decrease in effectiveness of public health and social measures or available diagnostics, vaccines, therapeutics

DocSun∙Computation∙MedLab∙Ltd∙mission∙is∙using∙technology∙to∙create∙life-long∙ Solutions∙ ∙∙∙The ∙article∙reference∙data∙from∙the∙CDC∙and∙WHO∙

Original links to the article:- https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern

FRENCH COVID HEALTH PASS.

What is a covid health pass

The people in France will need to show a covid health pass to enjoy usually routine activities .It will show that you are vaccinated or have tested negative for Covid-19 for access to public venues for more than 50 people. On August 9 the health pass requirement will be extended to a range of new settings, including long-distance transport, restaurants and cafés.
The border health pass will be useful when boarding a flight to France, of a health proof (complete vaccination scheme, or PCR or antigenic test performed less than 72 hours before boarding) in electronic version (via the TousAntiCovid application or other foreign electronic proof) or in paper version https://www.sante.fr/how-to-obtain-a-french-health-pass.

How useful will the covid health pass be

The Covid tests can be undertaken in anyway including using modern testing devises like those offered by research institutions like Docsun. But usage of these devises depends on policies of different organizationshttps://www.thelocal.fr/20211125/explained-the-new-rules-for-the-french-health-pass/
The activity health pass consists of the digital (via the TousAntiCovid application) or paper presentation of one of the following three health proofs to participate in certain activities in France:
Completion of a full vaccination schedule according to French rules (2 weeks after the 2nd injection of Pfizer, Moderna or Astra Zeneca, 4 weeks after the injection of Johnson and Johnson, 2 weeks after an injection in people who previously contracted Covid).
A PCR or antigenic test less than 48 hours prior to the event
A positive RT-PCR or antigenic test result demonstrating recovery from Covid-19, at least 11 days old and less than 6 months old.

Any of the following documents can be used as a covid health pass in France:
• Proof of having completed a vaccination program  (two doses of an EU-approved vaccine: Pfizer, Moderna, AstraZeneca or Johnson & Johnson)
• A negative PCR or antigen test taken within the last 48 hours
• A Covid-19 recovery certificate that is less than six months old
Anyone who enters an establishment without showing a valid pass can be fined €135 for a first offence.

Where a covid health pass is required

• Cinemas
• Libraries
• Nightclubs,
• Gaming rooms, casinos
• Museums
• Zoos, amusement parks, circuses
• Swimming pools and sports centres
• Theatres
• Concerts and festivals
• Indoor sports facilities
• Cruise ships, ferries
• Hotels, holiday resorts
• Cafés and restaurants
• Fairs and conferences
• Care homes
• Long-distance transport
• Medical establishments
• Hotels, holiday resorts and full-service camp sites
• Access to shopping centers

Who will the covid health pass apply to?

The health pass rules will apply to minors age 12 and over. The French citizens are also encouraged to undertake covid testing as a way to safeguard against further spread of the virus. It is argued that if one knows of their covid status then they will not knowingly infect the others. They are encouraged to use innovative devises like mobile apps. An example is the Docsun mobile app which uses OCT technology to scan and give a health report in less than ten minutes. The results are emailed to you to guarantee privacy https://www.youtube.com/watch?v=ZC8ppSTQgyE.
These devises have come up as part of the mobile health initiative that seeks to make healthcare affordable to everyone. These includes individuals who are limited geographically from accessing the requisite medical care that they need. The Docsun mobile app only needs to take a scan of the user, read the users vital signs like temperature and feed the data into its data base. The data is then processed to see if it matches any that is in its servers. The servers contain a lot of information from medical experts and certified by leading health organizations .This goes along way in making sure that the diagnosis provided is certifiably up-to-date.

Routine activities that will shield you from COVID- 19

The best ways recommended for protection getting vaccinated, AstraZeneca vaccine and Johnson and Johnson vaccine are among the available vaccines and most used. (Park, C. L at el, 2020) Currently, this is the leading prevention method; vaccines are to help our bodies be strong when fighting the diseases. The vaccination process is ongoing and there are hopes that in a few years to come everybody will be vaccinated making the world a step closer to stopping the spread.

 Wearing a mask is recommended by the health organization. (Park, C. L at el, 2020) Mask is to be worn covering to the nose area and the mouth, the right mask that is 3ply. Masks are to be worn in all public areas, transportations systems at all times. This applies to all people whether vaccinated or not.

Keep your hands clean by sanitizing, and washing them regularly. Effective hand sanitizers contain alcohol, which is formulated to be safe for use on hands. Other disinfectants, soaps, and bleach with the help of hot water are important steps in preventing the spread of the virus.  (Hu, X, at el, 2021) .Washing all surfaces with these kills the virus landing on the surfaces and constant cleaning is advised. It is important to note that these products are not used in self-medication. The only way for treatment is hospitalization and getting the right medication. 

 Maintain a 6 feet distance with other people whenever a person is in an outside setting with people you do not live in the same house with. (Park, C. L at el, 2020) Even if they are not sick there are asymptomatic people and are capable of spreading the disease. In a closed setting avoid close contact with any sick person. Avoid areas that are not well ventilated. This is to ensure that there is free circulation of air at all times.

 Monitor any symptoms at all times. Always check any alarming temperatures that are above normal. Any fever and cough or sneezing should not be taken lightly. 

Consumption of some supplements such as vitamin D, zinc, essential oils, and other nutritional supplements to boost immunity. Eating healthy foods and maintaining a healthy body is also a plus. With this, a person will be able to fight diseases comfortably and also prevent attacks.

Reference

Hu, X., Yan, H., Casey, T., & Wu, C. H. (2021). Creating a safe haven during the crisis: How organizations can achieve deep compliance with COVID-19 safety measures in the hospitality industry. International Journal of Hospitality Management92, 102662.

Park, C. L., Russell, B. S., Fendrich, M., Finkelstein-Fox, L., Hutchison, M., & Becker, J. (2020). Americans’ COVID-19 stress, coping, and adherence to CDC guidelines. Journal of general internal medicine35(8), 2296-2303.

DocSun∙Computation∙MedLab∙Ltd∙mission∙is∙using∙technology∙to∙create∙life-long∙ Solutions∙